Amgen - Media - In the News

print
mail

In the News

Corporate News


Apr. 16, 2012	Amgen Executes Civil Settlement Agreement for Federal Case in South Carolina
Nov. 1, 2012	Amgen Supports Assistance For Patients Affected By Hurricane Sandy
Oct. 25, 2012	Amgen and Kleiner Perkins Caufield & Byers Partner to Create New Spin-Out Biotech Company

Biosimilars in the News


Apr. 22, 2013	Amgen Welcomes European Commission Report on EU Biosimilars Uptake
Mar. 24, 2013	Amgen Supports World Health Organization�s Proposed Distinguishable Naming Policy for Biosimilars
Sept. 28, 2012	Amgen Statement on EMA Revised Biosimilars Q&A

Background Documents

Learn more about biosimilars

Enbrel® (etanercept) in the News


Jan. 16, 2013	Amgen Statement on Stroke Research
Apr. 24, 2009	Amgen and Wyeth announce ENBREL Support� Program
Mar. 18, 2009	Amgen Statement on Alzheimer's Case Study

Background Documents

Prescribing information for Enbrel®

ESAs in the News


Sep. 01, 2011	Amgen Statement on Proposed Changes to the Quality Incentive Program in Dialysis
Jun. 24, 2011	Amgen Posts Modified ESA Labeling
Jan. 19, 2011	Amgen Presents at MEDCAC Meeting on ESAs in Chronic Kidney Disease

Background Documents

Prescribing information for Aranesp®

Prescribing information for EPOGEN®

Pipeline in the News


May 15, 2013	Amgen at ASCO 2013
Nov. 5, 2012	Amgen at AHA Scientific Sessions 2012
May 16, 2012	Amgen at ASCO 2012

Prolia® (denosumab) in the News


Sep. 20, 2012	Press Release: FDA Approves New Indication For Prolia® (Denosumab) For The Treatment Of Bone Loss In Men With Osteoporosis At High Risk For Fracture
Sep. 20, 2012	Amgen Modifies U.S. Prescribing Information for Prolia® (denosumab)
Sep. 20, 2012	Amgen Modifies Prolia® Risk Evaluation and Mitigation Strategy (REMS) Materials (US)

Background Documents

Prescribing information for Prolia®

Neulasta® (pegfilgrastim) in the News


June 19, 2009	Amgen Introduces Neulasta FIRST STEP� Program

Background Documents

Prescribing information for Neulasta®

Nplate® (romiplostim) in the News


Dec. 6, 2011	Amgen and FDA Agree to Modify Nplate® Risk Evaluation and Mitigation Strategy

Jul. 27, 2011	Amgen Modifies U.S. Prescribing Information for Nplate® (romiplostim)

Background Documents

Prescribing information for Nplate®

Sensipar® (cinacalcet) in the News


Feb. 19, 2013	Letter to Healthcare Professionals

Background Documents

Prescribing information for Sensipar®

Vectibix® (panitumumab) in the News


Apr. 17, 2013	Amgen Statement on Additional Biomarker Analysis Beyond KRAS From Completed Phase 3 Study
Sep. 14, 2012	Amgen Modifies U.S. Prescribing Information for Vectibix® (panitumumab)
Jan. 12, 2012	Amgen Modifies U.S. Prescribing Information for Vectibix® (panitumumab)

Background Documents

Prescribing information for Vectibix®

XGEVA� (denosumab) in the News


June 8, 2012	Amgen Modifies U.S. Prescribing Information for XGEVA® (denosumab)
May 2, 2012	Amgen Modifies U.S. Prescribing Information for XGEVA® (denosumab)
Apr. 27, 2012	Amgen Modifies U.S. Prescribing Information for XGEVA® (denosumab)

Background Documents

Prescribing Information for XGEVA® (denosumab) (US)

footer